About
0.01USD-0.00 -14.33%
Closed • Updated at 09:59 GMT+00:00Market Cap$132.1K
Volume6.0K
Beta-0.74
RSI45.00
Gross Margin64.27%
Bioadaptives, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
Apr 28 2026
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
Oct 7 2025
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
Aug 20 2025
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
Jul 16 2025
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
Recent Videos

Shift to Cellular Health: Superhuman Protocol Challenge
May 08, 2026

Innovations in Pet Wellness, Modern Jewellery, and Luxurious Heirloom Jewelry
Jan 19, 2026

Elevating Skincare and Canine Health: Financial Clarity and Stem Cell-Based Supplements
Jan 19, 2026

Advancements in Biopharmaceuticals, Biotechnology, and Health Innovations
Dec 29, 2025
Translate